SORT OUT X - Combo Stent Versus ORSIRO Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3148 participants.
Also called NCT03216733
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,148 participants
- Registry
-
NCT03216733
-
- Other papers using this trial's data
- Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial
- Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03216733. Randomized; no masking; primary purpose treatment. Start 2017-06-01 (actual); primary completion 2018-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SORT OUT X - Combo Stent Versus ORSIRO Stent
- Acronym
- SORT OUT X
- Condition
- Coronary Heart Disease
- Condition
- Angina Pectoris
- Condition
- Myocardial Infarction
- Intervention (Device)
- COMBO
- Intervention (Device)
- ORSIRO
- Lead sponsor
- Aarhus University Hospital Skejby
- Collaborator
- Biotronik SE & Co. KG
- Collaborator
- OrbusNeich
Record details
- Record id
cardio:ct-nct03216733- Content hash
8cacefa907ce05730aada409854827653b23f16a3939124da60a6af10e7e5207